These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9147422)

  • 1. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
    AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
    Fournier S; Burguière AM; Flahault A; Vincent V; Treilhou MP; Eliaszewicz M
    Eur J Clin Microbiol Infect Dis; 1999 Jan; 18(1):16-22. PubMed ID: 10192709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group.
    Dubé MP; Sattler FR; Torriani FJ; See D; Havlir DV; Kemper CA; Dezfuli MG; Bozzette SA; Bartok AE; Leedom JM; Tilles JG; McCutchan JA
    J Infect Dis; 1997 Nov; 176(5):1225-32. PubMed ID: 9359722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen.
    Burman WJ; Stone BL; Rietmeijer CA; Maslow J; Cohn DL; Reves RR
    AIDS; 1998 Jul; 12(11):1309-15. PubMed ID: 9708410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
    Singer J; Thorne A; Khorasheh S; Raboud JM; Wu AW; Salit I; Tsoukas CM; Lemieux C; Shafran SD
    Int J STD AIDS; 2000 Apr; 11(4):212-9. PubMed ID: 10772083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
    Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
    Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress report: prophylaxis and therapy for MAC.
    Currier J
    AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients.
    Ruf B; Schürmann D; Mauch H; Jautzke G; Fehrenbach FJ; Pohle HD
    Infection; 1992; 20(5):267-72. PubMed ID: 1428183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.
    Kemper CA; Havlir D; Haghighat D; Dubé M; Bartok AE; Sison JP; Yao Y; Yangco B; Leedom JM; Tilles JG
    J Infect Dis; 1994 Jul; 170(1):157-64. PubMed ID: 8014492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
    May T; Brel F; Beuscart C; Vincent V; Perronne C; Doco-Lecompte T; Saint-Marc T; Dautzenberg B; Grosset J
    Clin Infect Dis; 1997 Sep; 25(3):621-9. PubMed ID: 9314450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAC management.
    PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Zweijpfenning SMH; Aarnoutse R; Boeree MJ; Magis-Escurra C; Stemkens R; Geurts B; van Ingen J; Hoefsloot W
    Chest; 2024 May; 165(5):1082-1092. PubMed ID: 38040054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
    Kemper CA; Meng TC; Nussbaum J; Chiu J; Feigal DF; Bartok AE; Leedom JM; Tilles JG; Deresinski SC; McCutchan JA
    Ann Intern Med; 1992 Mar; 116(6):466-72. PubMed ID: 1739237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Deschênes J; Phillips P; Turgeon F; Aoki FY; Toma E; Miller M; Duperval R; Lemieux C; Schlech WF
    J Infect Dis; 1998 Jan; 177(1):252-5. PubMed ID: 9419201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
    Chaisson RE; Benson CA; Dube MP; Heifets LB; Korvick JA; Elkin S; Smith T; Craft JC; Sattler FR
    Ann Intern Med; 1994 Dec; 121(12):905-11. PubMed ID: 7978715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.